B. Roniker

发表

Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction

B. Pitt, F. Zannad, W. Remme, 2003 .

The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction

J. López-Sendón, B. Pitt, F. Zannad, 2004, Cardiovascular Drugs and Therapy.

Long-term safety and efficacy of the selective aldosterone blocker eplerenone in patients with essential hypertension.

S. Oparil, E. Burgess, Y. Lacourciére, 2003, Clinical therapeutics.

Eplerenone , a Selective Aldosterone Blocker , in Patients with Left Ventricular Dysfunction after Myocardial Infarction

B. Pitt, F. Zannad, W. Remme, 2003 .

OR-53: Efficacy and safety of eplerenone, enalapril, and eplerenone/enalapril combination therapy in patients with left ventricular hypertrophy

N. Reichek, B. Pitt, B. Roniker, 2002 .

Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension.

W. White, B. Roniker, A. Carr, 2003, The American journal of cardiology.

Can Renin Status Predict the Antihypertensive Efficacy of Eplerenone Add‐On Therapy?

H. Krum, B. Roniker, Kaffa Fakouhi, 2003, Journal of clinical pharmacology.

Effects of eplerenone versus losartan in patients with low-renin hypertension.

L. Ruilope, W. White, T. MacDonald, 2005, American heart journal.

Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension.

L. Ruilope, E. Burgess, M. Kipnes, 2004, The American journal of cardiology.

Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction

V. Buckalew, M. Epstein, B. Roniker, 2002 .

EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION

B. Pitt, F. Zannad, W. Remme, 2003 .

OR-54: Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria

V. Buckalew, M. Epstein, B. Roniker, 2002 .

OR-55: Comparison of eplerenone and losartan in patients with low-renin hypertension

P. Conlin, M. Weinberger, B. Roniker, 2002 .

Effects of the Selective Aldosterone Blocker Eplerenone Versus the Calcium Antagonist Amlodipine in Systolic Hypertension

W. White, D. Duprez, Michael A. Weber, 2003, Hypertension.

The UVR wavelength dependence for lomefloxacin photosensitization of human skin.

J. Hawk, A. Young, B. Roniker, 1996, Journal of photochemistry and photobiology. B, Biology.

Co-Administration of Eplerenone with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin II Antagonist in Patients with Mild to Moderate Hypertension

H. Krum, R. Gordon, B. Roniker, 2002 .

P-70: The selective aldosterone blocker eplerenone is safe and efficacious for the long-term treatment of mild-to-moderate hypertension

E. Burgess, Y. Lacourciére, B. Roniker, 2002 .

Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

N. Reichek, B. Pitt, F. Zannad, 2003 .

Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients

H. Krum, B. Roniker, Kaffa Fakouhi, 2002, Hypertension.

Photoreactions with a fluoroquinolone antimicrobial: Evening versus morning dosing

R. Stern, B. Roniker, E. Swabb, 1994, Clinical pharmacology and therapeutics.

Eplerenone: a selective aldosterone receptor antagonist (SARA).

B. Roniker, D. Tolbert, J. Delyani, 2006, Cardiovascular drug reviews.

Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients.

S. Oparil, E. Saunders, J. Flack, 2003, Journal of the American College of Cardiology.

Cardiovascular Disease and Race Efficacy and Tolerability of Eplerenone and Losartan in Hypertensive Black and White Patients

S. Oparil, E. Saunders, J. Flack, 2003 .

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.

R. Weiss, M. Weinberger, B. Roniker, 2002, American journal of hypertension.

Experience collecting interim data on mortality: an example from the RALES study

S. Pocock, C. Furberg, J. Palensky, 2001, Current controlled trials in cardiovascular medicine.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

B. Pitt, F. Zannad, W. Remme, 2003, The New England journal of medicine.

Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension.

R. Weiss, M. Weinberger, B. Roniker, 2002, American journal of hypertension.

P-499: Efficacy and tolerability of eplerenone and losartan in hypertensive black patients and white patients

J. Flack, J. Pratt, B. Roniker, 2002 .